Company profile
Entia Ltd
Entia
Entia is making life better for people receiving cancer treatment.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts filed
AccountsLast accounts made up date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Confirmation Statement With Updates
Confirmation-statementCS01 | Transaction MzQ0MTEyMDcwNGFkaXF6a2N4
Published 28 Oct 2024 01:51
Incorporated
InceptionCompany registered at Companies House
Spinout profile
Company description
Entia produces a portable machine for the diagnosis of anaemia.
Entia is a multidisciplinary team spanning design, engineering, quality assurance, business development and innovation.
Project impact
Simplified blood testing
Public funding
Projects
Continuity of Development for a Home Oncology Management System
1 Jun 2020 to 30 Nov 2020
no public description
Chronic Kidney Disease patient management during Covid-19
1 Jun 2020 to 30 Nov 2020
Entia in partnership with the NHS has developed a new approach to managing chronic kidney disease. This project seeks to ensure that the solution developed addresses the needs of NHS trusts and renal centres across the UK.
Anaemia of Chronic Kidney Disease: Empowering patients by bringing treatment closer to them
1 Oct 2019 to 30 Jun 2021
"Entia, Hull University Teaching Hospitals NHS Trust and the Yorkshire & Humber Academic Health Science Network are developing a new approach to the management of patients with anaemia of chronic kidney disease. The project encompasses the late stage development of an anaemia management solution that will be co-designed and evaluated with patients and hea...
Affinity: Home blood count monitoring for personalised delivery of cancer therapy
1 Feb 2019 to 31 Jul 2021
"50% of people are expected to get cancer at some point in their life. Even with new therapies, many patients will experience unwanted side effects from their treatment that may range from minor psychological issues through to life threatening infections. With cancer patients spending a significant amount of time outside of healthcare facilities, it becom...
Early stage design: Self-management of anaemia
1 Sep 2017 to 31 May 2018
Over 3 million people suffer from iron-deficiency anaemia (IDA), a condition that can cause exhaustion and impair cognitive function. In a collaborative project, Eva Diagnostics is working alongside NIHR Diagnostics Evidence Cooperative London and the Department of Primary Care and Public Health, Imperial College London to undertake an early-stage design-...
Comprehensive blood counts in a handheld device: home monitoring in chemotherapy
1 Mar 2017 to 31 Mar 2019
For many individuals with cancer, chemotherapy forms a key aspect of treatment. Across the various types of chemotherapy, the majority carry significant side effects that often include the reduction of blood cell counts. The lowering of blood cell counts exposes individuals to higher risk of adverse events such as infection. Low blood counts are also the ...
Comprehensive blood counts in a handheld device
1 Oct 2015 to 30 Sep 2016
Eva Diagnostics is a medical technology and design company that is developing handheld diagnostic systems for the haematology sector. Building upon our existing platform technology, we are exploring the feasibility of a handheld diagnostic system capable of performing haematocrit, haemoglobin, white blood cell count, and platelet count from a single drop ...
Development of an anaemia diagnostic for the point
1 Jan 2015 to 30 Jun 2016
Eva Diagnostics is a medical design and engineering company commercialising technologies to improve the lives of anaemia sufferers across the globe. We have recently designed a new analysis technology that will lead to a low cost handheld device capable of diagnosing both the presence and type of anaemia. This device shall uniquely provide enough informat...